-
HIV Drugs Market Outlook: Future Trends Indicate a US$ 47.5 Billion Industry by 2034 with a Shift Toward Single-dose Regimens | Report by TMR
18 Mar 2025 11:28 GMT
… trials for its next-generation HIV treatment targeting drug- … to PrEP and ART medications.
Government & NGO … Biktarvy, Truvada, Descovy, Atripla
Expansion in long-acting therapies … on affordable HIV treatment
Teva Pharmaceutical Industries Ltd.
Generic …
-
Gilead Sciences - Leader In HIV Medicines
14 Mar 2025 20:21 GMT
… , develops, and commercializes medicines for virology, oncology and … liposomal formulation for the treatment of serious invasive fungal … of market products includes Atripla, Cayston, Descovy for …
Pavella - Undiscovered Biotechnology Stock
Xeris Biopharma …
-
HIV Treatment Information for Pregnant Women
30 Jan 2025 20:04 GMT
Atripla*
efavirenz 600 mg
emtricitabine 200 … Oral Tablet
Embryo-Fetal Toxicity
Atripla Label
Biktarvy*
bictegravir 50 mg … information available for the approved treatment dose of 600 mg twice … information available for the approved treatment dose of 600 mg …
-
3 Biotechnology Stocks With Promising Pipelines
02 Nov 2024 00:15 GMT
… strong biotech stocks Amgen Inc. (AMGN), Regeneron Pharmaceuticals, Inc … personalized medicine, and rapid acceleration in drug discovery … phase 3 PHOTON trial continued to demonstrate … FDA approval for Dupixent® (dupilumab) as an add-on maintenance treatment …
-
27 Individuals Indicted for Buying and Selling Wholesale Quantities of Misbranded and Diverted Prescription Drugs Resold to the Public Through Retail Pharmacies in Puerto Rico
27 Sep 2024 16:15 GMT
… through licensed pharmaceutical distribution channels. By selling diverted prescription drugs and … Ellipta, Arnuity Ellipta, Aspen Dexamfetamine, Atripla, Atrovent, Azopt, Bepreve, Biktarvy, … on the FDA website. If someone is having a medical emergency, …
-
January - March 2019 | Potential Signals of Serious Risks/New Safety Information Identified from the FDA Adverse Event Reporting System (FAERS)
16 Sep 2024 17:01 GMT
… -acting antiviral drugs for the treatment of chronic … labeling, and the “Medication Guide” were updated …
Zepatier labeling
An FDA Drug Safety Communication for … lamivudine, tenofovir disoproxil fumarate)
Atripla (efavirenz, emtricitabine, tenofovir …
-
FTC v Actavis and pricing practices spearhead rise in US pharmaceutical antitrust cases
12 Aug 2024 10:51 GMT
… trials both concerned the same product, Opana. The first Opana trial … from older HIV treatments to newer treatments.[93] But … allegations that the Medicare Drug Price Negotiation programme … requires pharmaceutical manufacturers to provide outpatient drugs at …
-
Human medicines European public assessment report (EPAR): Eviplera, emtricitabine,rilpivirine,tenofovir disoproxil, Date of authorisation: 27/11/2011, Revision: 26, Status: Authorised
19 Jun 2024 17:20 GMT
… after 48 weeks of treatment were considered to have … responded to treatment.
Eviplera has also been … switched from their current HIV treatment to Eviplera. Patient’s … boosted protease inhibitor, or the medicine Atripla. The main measure of …
-
Chronotherapy: Why Timing Drugs to Our Body Clocks May Work
10 Jun 2024 09:30 GMT
… 2022 randomized, controlled trial from the University … the insomnia drug Ambien, the HIV antiviral Atripla, and … "retrospective randomized trials are needed to establish … doctors use chronotherapy and before medical organizations include it in treatment …
-
20 Biggest Publicly Traded Biotech Companies
26 May 2024 03:14 GMT
… tablet regimen for HIV treatment, Atripla, which simplified dosing … treatment in 1987 and the first single-pill, two-drug … and 36 clinical trials before the first … global pharmaceutical and biotechnology company. The company introduced innovative medicines …
About
© 1995-2025